Tularemia with Sepsis, Hemodynamic Instability, or End-Organ Dysfunction: Treatment Approach

Severe Tularemia presenting with haemodynamic compromise, evidence of end-organ involvement, a requirement for respiratory support, or signs of sepsis defines a critical clinical scenario that warrants a distinct, more aggressive antimicrobial strategy.

Clinical Scenario

This protocol covers patients with hemodynamic instability, end-organ dysfunction, need for respiratory support, or other manifestations of sepsis or severe illness in the context of confirmed or suspected Tularemia.

Treatment Approach — Partial Overview

For severe disease, initial treatment with an aminoglycoside is the preferred approach, supported by more robust clinical experience and published evidence. Combination therapy using two distinct classes of effective antimicrobials may also be considered in selected patients. Agent selection, combination options, sequencing, and dosing are detailed in the full protocol.

Instant Access to Structured Evidence-Based Regimens

References

For patients with severe infection, indicated by hemodynamic instability, end-organ dysfunction, need for respiratory support, or other signs of sepsis or severe illness, health care providers should consider treating initially with an aminoglycoside if possible because of the more robust clinical experience and published evidence of aminoglycoside use for severe disease.

Health care providers also can consider prescribing combination therapy with two classes of effective antimicrobials (e.g., gentamicin plus ciprofloxacin or gentamicin plus doxycycline).

View source ↗